Regulation of cells and organisms
OwnerVictor TETS, Georgy TETSinventors
Life of this patent
Estimating the term…
Abstract
The invention relates to medicine, biology, veterinary, pharmacology diagnostics, agriculture, ecology, meteorology, seismology, construction biotechnology, biomanufacturing and provided herein are products and methods for managing cells behavior, memory of cells and erasure of cell memory. The present invention describes products and methods that, unlike the known ones, make it possible to control the properties of cells and organisms without the use of mutagens and/or the special introduction of genes and/or use of specific gene tools and/or changing its environmental conditions.
Claims20
A method for treating a cancer, wherein
- a. a cell, which is not a chimeric antigen receptor T-cell, is treated with one or more of an RNase, a DNase, an enzyme that has DNase and/or RNase activity, an antibody that binds to an RNA and an antibody that binds to a DNA;
- b. following treatment, a therapeutically effective amount of the treated cells are administered to a patient suffering from a cancer;
- and
- c. following administration, the treated cells reduce the symptoms of the cancer.
A method of treating a cancer, wherein,
- a. a cell, which is not a chimeric antigen receptor T cell, is first treated with at least one of an RNase, a DNase, an enzyme that has DNase and/or RNase activity, an antibody that binds to an RNA and an antibody that binds to a DNA
- b. following the first treatment, the cells receive a second treatment with a microbial or a eukaryotic cell, including a solid tumor cell or a circulating cancer cell and their components;
- wherein,
- c. following the treatment, the anticancer activity of the treated cells is greater than cells that do not receive the first and second treatment.
A method for treating a cancer, wherein
- a. a cell, comprising a combination of leukocytes and platelets, is treated with one or more of an RNase, a DNase, an enzyme that has DNase and/or RNase activity, an antibody that binds to an RNA and an antibody that binds to a DNA.
- b. following treatment, a therapeutically effective amount of the treated cells are administered to a patient suffering from a cancer, and
- c. following administration, the treated cells reduce the symptoms of the cancer.
Dependencies are inferred from the claim text.